ProCE Banner Activity

Small Molecule Inhibitor Landscape in Mature B-Cell Lymphomas: Current Status, Future Directions, and Clinical Considerations

Slideset Download
Download this slideset from Anthony Perissinotti, PharmD, BCOP, with the latest insights for pharmacists on the use of BTK, PI3K, and BCL-2 targeted agents for patients with B-cell lymphomas.

Released: March 12, 2020

Expiration: March 11, 2021

No longer available for credit.

Share

Faculty

Anthony Perissinotti

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Faculty Disclosure

Primary Author

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan